These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13296879)

  • 21. Relative concentrations of N15 in urinary ammonia N and urea N after feeding N15-labeled compounds.
    WU H
    J Gen Physiol; 1951 Mar; 34(4):403-9. PubMed ID: 14824507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of 19-nortestosterone and of 19-nortestosterone cyclopentylpropionate].
    FERIN J
    Ann Endocrinol (Paris); 1955; 16(6):895-9. PubMed ID: 13327447
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the synthetic anabolic steroid, 17-ethyl-19-nortestosterone, on serum proteins, lipoproteins and lipids in human subjects.
    DANIELSON E; SACHS BA; WESTON RE
    J Clin Endocrinol Metab; 1956 Oct; 16(10):1388-91. PubMed ID: 13367178
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of testosterone, nandrolone and precursors in horse hair.
    Anielski P; Thieme D; Schlupp A; Grosse J; Ellendorff F; Mueller RK
    Anal Bioanal Chem; 2005 Nov; 383(6):903-8. PubMed ID: 16261327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anabolic, androgenic and antigonadotrophic properties of five synthetic 19-nortestosterone analogs.
    PERRINE JW
    Acta Endocrinol (Copenh); 1961 Jul; 37():376-84. PubMed ID: 13734544
    [No Abstract]   [Full Text] [Related]  

  • 26. Anabolic steroids in polytrauma patients. Influence on renal nitrogen and amino acid losses: a double-blind study.
    Hausmann DF; Nutz V; Rommelsheim K; Caspari R; Mosebach KO
    JPEN J Parenter Enteral Nutr; 1990; 14(2):111-4. PubMed ID: 2112616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adverse effects of anabolic steroids on serum lipids.
    Labib M; Haddon A
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():263-4. PubMed ID: 8791993
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the influence of anabolic steroids on experimental atheroma: 17-alphaethyl-19-nortestosterone (nilevar).
    CAMPBELL RS; LAWRIE TD; LIEBESCHUETZ HJ; McALPINE SG; PIRRIE R; RIFKIND BM
    Am Heart J; 1960 Nov; 60():799-803. PubMed ID: 13690274
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference population.
    Hullstein I; Sagredo C; Hemmersbach P
    Drug Test Anal; 2014; 6(11-12):1163-9. PubMed ID: 25388436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 19-nortestosterone detection in canine plasma after intramuscular administration of 19-nortestosterone phenylpropionate.
    Macdougall DF; Jondorf WR
    Res Vet Sci; 1989 Nov; 47(3):399-401. PubMed ID: 2595098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catabolic effect of dihydrotachysterol and anabolic action of 17-ethyl-19-nortestosterone on the uptake of radio sulphur in a healing fractured bone of the rat.
    KOWALEWSKI K
    Acta Endocrinol (Copenh); 1958 May; 28(1):119-23. PubMed ID: 13532383
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myoanabolic steroids and selective androgen receptor modulators: mechanism of action and perspectives].
    Tóth M
    Orv Hetil; 2009 Nov; 150(45):2051-9. PubMed ID: 19861292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The popliteal-artery entrapment syndrome in a patient using anabolic steroids.
    Lepori M; Perren A; Gallino A
    N Engl J Med; 2002 Apr; 346(16):1254-5. PubMed ID: 11961162
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experimental studies with 4-hydroxy-19-nortestosterone-cyclopentylpropionate].
    Luchmann A; Schmitz I; Breuer H
    Arzneimittelforschung; 1966 Apr; 16(4):474-8. PubMed ID: 6014254
    [No Abstract]   [Full Text] [Related]  

  • 35. N15 distribution among chemical components of liver fractions in rats fed N15 -labeled p-dimethylamino-azobenzene.
    BERENBOM M
    Cancer Res; 1959 Nov; 19():1045-9. PubMed ID: 13799159
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacologic studies on a new 19-nor protein anabolic steroid. I. A study of the toxicity and action of 4-hydroxy-19-nortestosterone-17-cyclopentylpropionate].
    Kikuta K
    Zasshi Tokyo Ika Daigaku; 1967 Sep; 25(5):531-63. PubMed ID: 5625985
    [No Abstract]   [Full Text] [Related]  

  • 37. [Apropos of the indications for anabolic steroids in the treatment of chronic hepatic lesions].
    Blahniková L; Horký J
    Gastroenterologia; 1967; 107(6):354-9. PubMed ID: 6052562
    [No Abstract]   [Full Text] [Related]  

  • 38. [On some new water-soluble derivatives of 19-nortestosterone].
    GIANNINI M; FEDI M
    Boll Chim Farm; 1960 Jan; 99():24-6. PubMed ID: 13827850
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the nephrotrophic action of several 19-nortestosterone derivatives].
    LOMONACO F
    Sperimentale; 1960; 110():220-30. PubMed ID: 13763286
    [No Abstract]   [Full Text] [Related]  

  • 40. Anabolic, androgenic and myotropic activities of derivatives of 7alpha-methyl-19-nortestosterone.
    LYSTER SC; DUNCAN GW
    Acta Endocrinol (Copenh); 1963 Jul; 43():399-411. PubMed ID: 13931986
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.